Shanghai Haikang Pharmaceutical Tech.& Deve. Co., Ltd., which consists of two business segments research and development (R&D) of biological drug and plant extracts, is located in State Biotech Pharmaceutical industrial base, Shanghai International Medical Zone. The company has strong R&D background and has introduced several professors from Cancer Institute Chinese Academy of Medical Sciences, which have laid a solid foundation for her high-growth and core competitiveness. In the aspect of biological new drug R&D, enterprise exists several monoclonal antibodies as key development projects, all that with independent intellectual property rights are reported in clinical stage or preclinical stage respectively.